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ABSTRACT
Objectives In older patients, the the D-dimer test for
pulmonary embolism has reduced specificity and is
therefore less useful. In this study a new, age dependent
cut-off value for the test was devised and its usefulness
with older patients assessed.
Design Retrospective multicentre cohort study.
Setting General and teaching hospitals in Belgium,
France, the Netherlands, and Switzerland.
Patients 5132 consecutive patients with clinically
suspected pulmonary embolism.
Intervention Development of a new D-dimer cut-off point in
patients aged >50 years in a derivation set (data from two
multicentre cohort studies), based on receiver operating
characteristics (ROC) curves. This cut-off value was then
validated with two independent validation datasets.
MainoutcomemeasuresTheproportionofpatientsinthe
validation cohorts with a negative D-dimer test, the
proportion in whom pulmonary embolism could be
excluded, and the false negative rates.
Results The new D-dimer cut-off value was defined as
(patient’s age×10) μg/l in patients aged >50. In 1331
patientsinthe derivationsetwithan “unlikely”score from
clinical probability assessment, pulmonary embolism
could be excluded in 42% with the new cut-off value
versus 36% with the old cut-off value (<500 μg/l). In the
two validation sets, the increase in the proportion of
patients with a D-dimer below the new cut-off value
compared with the old value was 5% and 6%. This
absolute increase was largest among patients aged >
70 years, ranging from 13% to 16% in the three datasets.
Thefailurerates(allages)were0.2%(95%CI0%to1.0%)
in the derivation set and 0.6% (0.3% to 1.3%) and 0.3%
(0.1% to 1.1%) in the two validation sets.
Conclusions The age adjusted D-dimer cut-off point,
combined with clinical probability, greatly increased the
proportion of older patients in whom pulmonary
embolism could be safely excluded.
INTRODUCTION
MeasurementofD-dimerconcentrationinthebloodis
a valuable tool in the diagnostic investigation of
patients with suspected pulmonary embolism. A D-
dimer concentration below the conventional cut-off
point of 500 μg/l combined with a “low/intermediate”
or“unlikely”clinicalprobabilitycansafelyruleoutthe
diagnosis in about 30% of patients with suspected pul-
monary embolism.
1-3 However, the D-dimer concen-
tration increases with age and its specificity for
embolism decreases, which makes the test less useful
to exclude pulmonary embolism in older patients.
4-9
Indeed,thetestisabletoruleoutpulmonaryembolism
in 60% of patients aged <40 years, but in only 5% of
patients aged >80.
8
If the D-dimer test is combined with an “unlikely”
clinical probability
10 to rule out pulmonary embolism,
10%ofpatients>75yearsoldversus32%ofpatientsof
allagesdonotneedfurtherdiagnostictesting;thenum-
berneededtotestforonenegativetestresultis10.6and
3.1, respectively.
9 Raising the cut-off value to various
points between 600 μg/l and 1000 μg/l increased spe-
cificity, but this came at the cost of safety, with more
false negative test results.
11 In this analysis, however,
no stratification was made for clinical probability.
By constructing receiver operating characteristics
(ROC) curves, we derived a new, age dependent D-
dimer cut-off value and analysed its safety and clinical
utility, in combination with clinical probability assess-
ment,fortheexclusionofpulmonaryembolismintwo
large prospective cohort studies of patients with sus-
pected pulmonary embolism. We then validated the
outcome in two other large management studies.
METHODS
Derivation set
We analysed the combined data from two prospective
multicentre cohort studies, which included 1721
consecutive outpatients with suspected pulmonary
embolism.
112These outcome studies were designed to
evaluatediagnosticstrategiesforpulmonaryembolism,
combining clinical probability assessment, D-dimer
measurement, lower limb venous compression ultraso-
nography, and helical computed tomography.
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emergency department of four general and teaching
hospitals were included if they had a clinical suspicion
of pulmonary embolism. The inclusion and exclusion
criteria and the results of the two studies have been
published previously.
112
The first study, conducted at Geneva University
Hospital, Geneva, and Centre Hospitalier Universi-
taire Vaudois, Lausanne, both in Switzerland, and at
Angers University Hospital, Angers, France, between
October 2000 and June 2002, comprised 965
patients.
12 The second study, conducted at Geneva
University Hospital, Angers University Hospital, and
Hôpital Européen Georges Pompidou, Paris, France,
between September 2002 and October 2003, com-
prised 756 patients.
1 Both studies were approved by
the institutional review boards of each participating
institution and written informed consent was obtained
from all patients.
Allpatientsunderwentasequentialdiagnosticinves-
tigation, including plasma D-dimer measurement by
an enzyme linked immunosorbent assay (rapid
ELISA assay, VIDAS D-Dimer Exclusion, Biomér-
ieux, Marcy-l’Etoile, France). For each patient, the
Geneva score
13 was assessed to assign the patient to a
clinical probability category—with possible override
by implicit assessment in case the result conflicted
with the assessor’s clinical judgment.
14 Variables
included in the Wells clinical prediction rule for pul-
monary embolism
10 were also systematically and pro-
spectively collected, allowing calculation of the Wells
score.
Pulmonaryembolismwasruledoutby(a)aD-dimer
concentration<500μg/l,exceptinpatientswithahigh
clinical probability, in the second study; (b) negative
results from lower limb venous compression ultraso-
nography and from helical computed tomography in
patients with a low or intermediate clinical probability
ofpulmonaryembolism;or(c)byanormalventilation-
perfusionlungscanoranormalpulmonaryangiogram
in patients with a high clinical probability or with
inconclusive helical computed tomogram. Pulmonary
embolism was established by (a) finding a proximal
deep vein thrombosis on lower limb ultrasonography;
(b) a positive result from helical computed tomogra-
phy; or (c) a high probability ventilation-perfusion
lung scan or a positive pulmonary angiogram in high
clinical probability patients with negative results from
both compression ultrasonography and helical com-
puted tomography, and in patients with inconclusive
computed tomogram.
Patients were followed upby theirfamily physicians
andwereinterviewedbytelephonebyoneofthestudy
coordinators at the end of three months’ follow-up.
The outcome was an estimate of the three month
thromboembolic risk in patients in whom pulmonary
embolism was considered ruled out by the initial diag-
nostic investigations and who did not receive anti-
coagulants during follow-up. Confirmation of venous
thromboembolic events during follow-up were estab-
lished with the usual criteria.
1212
Validation set 1
For the first validation set, data from a third prospec-
tive multicentre cohort study were used.
2 This study
evaluatedtheclinicaleffectivenessofasimplifiedalgo-
rithmusingthedichotomisedWellsrule,D-dimertest-
ing, and computed tomography in patients with
suspected pulmonary embolism. Briefly, all consecu-
tiveinpatientsandoutpatientswithclinicallysuspected
acutepulmonaryembolismwereeligibleforthestudy,
which was conducted between November 2002 and
August 2004 in 12 hospitals in the Netherlands. The
institutionalreviewboardsofallparticipatinghospitals
approvedthestudyprotocol.Theresultsandtheinclu-
sionandexclusioncriteriawerepublishedpreviously.
2
The study population comprised 3306 patients.
Allpatientsunderwentasequentialdiagnosticinves-
tigation,consistingofclinicalprobabilitycalculation,a
D-dimer test (Tinaquant, Roche Diagnostica, Man-
nheim, Germany or Vidas D-Dimer Exclusion, Bio-
merieux) and computed tomography scanning. At
admission, the clinical probability of pulmonary
embolism was calculated by the treating physician
using the Wells score. According to the protocol, a D-
dimer test was performedonly in patients with a Wells
score of ≤4. Pulmonary embolism was ruled out by (a)
an unlikely clinical probability (Wells score ≤4) com-
bined with a D-dimer test ≤500 μg/l or (b) a negative
helical computed tomogram in patients with a “likely”
clinical probability or an abnormal D-dimer test. Pul-
monaryembolismwasestablishedbyapositivehelical
computed tomogram. The follow-up was performed
the same way as in the derivation set studies.
Validation set 2
For the second validation set, data from a fourth pro-
spective multicentre study were used.
3 This study
investigated in a randomised non-inferiority trial
whether the addition of venous ultrasonography to
multi-detector computed tomography improved the
detectionofpulmonaryembolism.Consecutiveoutpa-
tientswithclinicallysuspectedacutepulmonaryembo-
lism were eligible for the study, which was conducted
betweenJanuary2005andAugust2006insixhospitals
in France, Belgium, and Switzerland. The institutional
review boards of all participating hospitals approved
the study protocol. The results and inclusion and
exclusion criteria were published previously.
8 The
study population comprised 1812 patients.
Allpatientsunderwentasequentialdiagnosticinves-
tigation,consistingofclinicalprobabilitycalculation,a
D-dimer test (Vidas D-Dimer Exclusion, Biomerieux)
and then randomisation to either multi-detector com-
putedtomographyaloneorcompressionultrasonogra-
phy of the legs followed by computed tomography. At
admission, the clinical probability was calculated by
the treating physician using the revised Geneva
score.
15 Pulmonary embolism was ruled out by (a)a
non-high clinical probability (revised Geneva score
<11) combined with a D-dimer test <500 μg/l or (b)a
negative helical computed tomography result in
patients with a high revised Geneva score or an
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was established by a positive result from helical com-
puted tomography or compression ultrasonography.
The follow-up was performed in the same way as the
previous studies.
Data analysis
Inthederivationsetandvalidationset1theWellsclin-
ical prediction rule for pulmonary embolism was cal-
culated in all patients, and patients were classified
according to the dichotomised Wells score as likely
orunlikelytohavepulmonaryembolism.Invalidation
set 2, the revised Geneva score was calculated in all
patients and classified as a high or non-high (low or
intermediate) score.
To derive a new D-dimer cut-off value, we divided
patientsaged>50inthe derivationset into10 yearage
groups. We constructed receiver operating character-
istics (ROC) curves of the D-dimer test for each age
group to find the best cut-off value (with a sensitivity
of100%andthehighestcorrespondingspecificity).We
plottedtheD-dimercut-offlevelagainstagegroupand
performed linear regression analysis to obtain the
regression coefficient, representing the increase in D-
dimer cut-off value per decade. This coefficient was
dividedby10tofindthecoefficientperyear.Thiscoef-
ficient was the multiplication factor for age in the new
age-adjusted cut-off value.
We then calculated the proportion of patients with a
negativeD-dimertestresult(asdefinedbythenewcut-
off point), the proportion in whom pulmonary embo-
lism could be excluded (based on an “unlikely” Wells
score or “non-high” revised Geneva score plus the
negative D-dimer test result), and the false negative
rates(thatis,thosepatientswhohadpulmonaryembo-
lism in the diagnostic investigation or during follow-
up). The number of patients needed to test by D-
dimer to rule out one pulmonary embolism was com-
puted as 1 divided by the proportion of patients with a
negative D-dimer test result in each age group.
16
Inthevalidationsets,D-dimertestresultsweremiss-
ing in a large proportion of patients with a “likely”
Wells score or high revised Geneva score. Therefore,
the age adjusted D-dimer cut-off point was validated
only in patients with an “unlikely” or non-high clinical
probability score in these two cohorts.
We calculated exact 95% confidence intervals using
CIA software version 1.0 (Gardner et al. Confidence
Interval Analysis (CIA), BMJ Books). All other analyses
were performed with SPSS version 15.0 (SPSS, Chi-
cago, IL).
RESULTS
Derivation of the new cut-off value
Ofthe1721patientsincludedinthederivationset,416
(24.2%) had pulmonary embolism. The D-dimer test
was not performed for nine patients from the second
study with high clinical probability (all nine had pul-
monary embolism diagnosed during initial investiga-
tion). Table 1 shows the clinical characteristics of the
patients in the derivation cohort.
The figure shows the increase in optimal D-dimer
cut-off value by patient age group, obtained from the
ROC curves for each group. The cut-off point
increased from 512 μg/l in patients <50 years old to
934μg/linpatients>80yearsold.Theregressioncoef-
ficient was 112 (SE 12.03) μg/l increase per decade, or
11.2 μg/l increase per year (r
2=0.966). To be conserva-
tiveandtofacilitateclinicalusefulnessandpracticality,
we considered a 10 μg/l increase per patient year to be
an appropriate new D-dimer coefficient. Starting from
the conventional cut-off point of 500 μg/l until the age
of50,forolderpatientsthepatientageshouldbemulti-
plied by 10 to calculate the age adjusted cut-off value.
Derivation set outcome
With the conventional cut-off value, the VIDAS D-
dimertestwasnormal(<500μg/l)in512/1712patients
(29.9%), and none had pulmonary embolism during
the initial investigation or the three month follow-up
(0%, 95% CI 0% to 0.7%). The number of patients
needed to test to find one normal D-dimer test result
was 3.3. The Wells score could not be computed in 54
ofthepatients,mainlybecauseinformationonthelike-
lihood of an alternative diagnosisto that of pulmonary
embolism was missing (n=42).
Table 1 |Baseline characteristics of the derivation and validation cohorts of patients with
clinically suspected pulmonary embolism used to produce an age dependent cut-off value for
the D-dimer test for pulmonary embolism. Values are numbers (percentages) of patients
unless specified otherwise
Characteristic
Derivation set
(n=1721)
Validation set 1
(n=3306)
Validation set 2
(n=1819)
Age (years):
Mean (SD) 61 (19) 53 (18) 59 (19)
Median (interquartile range) 63 (45-76) 51 (39-68) 61 (45-75)
Female 1016 (59) 1896 (57) 922 (51)
History of venous thromboembolism 308 (18) 480 (15) 300 (17)
Active malignancy 164 (10) 474 (14) 127 (7.0)
Recent surgery 94 (5.5) 46 (1.4) 94 (5.2)
Haemoptysis 80 (4.6) 176 (5.3) 83 (4.6)
Heart rate >100 beats/min 362 (21) 867 (26) 369 (20)
Clinical signs of deep vein thrombosis 246 (14) 190 (5.7) 153 (8.4)
Age (years)
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Fig 1 | Optimal cut-off values for D-dimer test for pulmonary
embolism by age in patients with an unlikely clinical
probability of pulmonary embolism (sensitivity set at 100%)
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μg/l), we found that D-dimer test results were negative
in 615/1712 patients (46.2%, number needed to test
2.2). This resulted in a 20.1% (95% CI 16.9% to 23.8%)
relative increase in the number of patients in whom D-
dimer levels were considered normal. Of these 615
patients, five had pulmonary embolism during investi-
gation or three month follow-up (0.8%, 0.4% to 1.9%).
Table 2 shows the proportion of the 1331 patients
with an unlikely clinical probability in whom pulmon-
ary embolism could be excluded based on the conven-
tional and the age adjusted D-dimer cut-off values.
There was a 17.4% (95% CI 14.3% to 21.1%) increase
in the number of patients with a negative D-dimer test
resultwhentheageadjustedcut-offvaluewasused.The
false negative rate was 0 (0%, 0% to 0.8%) for the con-
ventional cut-off value compared with 1 (0.2%, 0% to
1.0%) for the age adjusted cut-off value. Table 2 also
shows the increase in the proportion of patients with
anunlikelyclinicalprobabilityinwhomD-dimerlevels
would be considered normal for specific age groups by
using the age adjusted cut-off value: this increase was
highest among the oldest patient groups (>70 years),
with an absolute increase of 14% compared with the
conventional cut-off point.
External validation
Theconceptofusinganincreasingcut-offvalueforthe
D-dimer test according to age was validated in two
independent cohorts of patients with suspected pul-
monary embolism. The clinical characteristics of the
patients in these cohorts were similar to those of the
patients in the derivation set (table 1).
Validation set 1
Of the 3306 patients included in validation set 1, 674
(20.4%) had pulmonary embolism. In 41 of the 2206
patients with an unlikely clinical probability of pul-
monary embolism, D-dimer test results were recorded
only qualitatively and were therefore missing for this
analysis. In another seven patients age was not docu-
mented, leaving 2158 patients. Among these, 983
patients had a negative D-dimer test result with the
conventional cut-off value, of whom two (0.2%, 95%
CI 0.1% to 0.7%) had pulmonary embolism during
the diagnostic investigation or three month follow-up.
Withtheageadjustedcut-offvalue,1093patientshada
negative D-dimer test result, of whom seven (0.6%,
0.3% to 1.3%) had pulmonary embolism. Table 3
shows the proportion of patients in whom pulmonary
embolism could be excluded based on the old and the
new cut-off values.
The age adjusted cut-off value resulted in an 11.2%
(9.3%to13.3%)increaseinthenumberofpatientswith
a negative D-dimer test result. The increase in the pro-
portion of patients in whom pulmonary embolism
could be ruled out (that is, unlikely clinical probability
with a D-dimer level below the cut-off) from using the
age adjusted cut-off value was most prominent among
patients in the age groups >70 years, with an absolute
increase of 16% (table 3).
The data for validation set 1 came from a study in
which two different D-dimer tests were used.
2 We
therefore performed separate analyses for the two D-
dimer tests. There was no difference between the two
tests in the false negative rate for the age adjusted D-
dimer cut-off value (table 4).
Validation set 2
Of the 1812 patients included in the second validation
set,375(20.7%)hadpulmonaryembolism.Amongthe
1643 patients who had a non-high revised Geneva
score, 561 patients (34%, number needed to test 2.9)
had a normal D-dimer test result according to the
Table 2 |Proportion of patients in the derivation set with an unlikely clinical probability of pulmonary embolism* in whom
pulmonary embolism could be excluded based on a D-dimer test result below the cut-off value: comparison of different cut-
off values stratified by age group
All patients
Age range (years)
51-60 61-70 71-80 >80
No (%) of patients 1331 189 (14) 211 (16) 265 (20) 198 (15)
Median (IQR) age (years) 61 (44-75) 56 (54-58) 66 (63-68) 76 (73-78) 85 (82-88)
Conventional cut-off value† †
No (%, 95% CI) of patients below cut-off value: 477(36,33to39) 97 (51, 44 to 58) 63 (30, 24 to 36) 40 (15, 11 to 20) 11 (6, 3 to 10)
With false negative result 0 (0, 0 to 0.8) 0 (0, 0 to 3.8) 0 (0, 0 to 5.8) 0 (0, 0 to 8.8) 0 (0, 0 to 26)
Number needed to test‡ 2.8 1.9 3.3 6.6 18
Age adjusted cut-off value† †
No (%, 95% CI) of patients below cut-off value: 560(42,39to45) 102(54,47to61) 76 (36, 30 to 43) 75 (28, 23 to 34) 41 (21, 16 to 27)
With false negative result 1 (0.2, 0 to 1.0) 0 (0, 0 to 3.6) 0 (0, 0 to 4.8) 1(1.3,0.2to7.2) 0 (0, 0 to 8.6)
Number needed to test‡ 2.4 1.9 2.8 3.5 4.8
Increase in percentage of patients below
cut-off value:
Absolute 6.3 2.6 6.2 13 15
Relative 17 5.2 21 67 273
IQR=interquartile range
*Based on Wells clinical decision rule.
†Conventional cut-off value for D-dimer test=500 μg/l, age adjusted cut-off value=(age×10) μg/l (if age >50).
‡Number needed to test to find one normal D-dimer test result
RESEARCH
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95% CI 0% to 0.7%) had pulmonary embolism during
theinitialinvestigationorthreemonthfollow-up.With
the age adjusted cut-off value, 663/1643 patients had a
negativeD-dimertestresult(40.4%,numberneededto
test 2.5) (table 5). This resulted in an 18.2% (15.0% to
21.4%)increase in the number ofpatients in whomthe
D-dimertestwasnegative.Thefalsenegativerate with
the age adjusted cut-off value was 2 (0.3%, 0.1% to
1.1%). Again use of the age adjusted cut-off value had
the greatest effect in the older age groups (table 5).
DISCUSSION
Thestudyshowsthatanageadjustedcut-offlevelforthe
D-dimertestforexclusionofpulmonaryembolismdou-
bles the proportion of older patients (>70 years) in
whom pulmonary embolism can be safely excluded in
comparison with the conventional cut-off value of
500 μg/l. We derived and validated this new cut-off
value in three large cohorts of consecutive patients
with suspected pulmonary embolism, totalling over
5000 patients. In these three cohorts, the number of
older patients in which pulmonary embolism could be
safely ruled out was consistent, between 25% and 30%.
The clinical usefulness of the new cut-off value
increased significantly with age: the proportion of
patients in whom pulmonary embolism could be ruled
out with the new cut-off value was a third higher in
patients older than 50 and almost twice as high in
patients older than 70 compared with the conventional
cut-off. Increasing the cut-off point to improve clinical
utility did not come at the expense of safety: in the deri-
vation and validation sets there was no difference in the
false negative rate, and for the total population and for
patientsaged>50yearsthe95%upperconfidencelevels
were well below 3% with the new cut-off value.
Impact in the clinical setting
A recent cost effectiveness analysis showed that
D-dimer measurement as part of the diagnostic inves-
tigation of patients with suspected pulmonary embo-
lism was cost saving until the age of 79 years.
17 After
80years,thetest’sclinicalutilitywastoolowtobecost
effective, and the costs of strategies with or without D-
dimer testing were similar. This analysis was based on
the conventional cut-off point of 500 μg/l for ELISA
based assays. It can be expected, however, that the
test’scosteffectivenessinolderpatientswouldincrease
withthenewcut-offvalue,asthenumberneededtotest
waslowerwiththeageadjustedcut-offvaluecompared
with the conventional cut-off value in patients
>80 years old (3.5 versus 6.6). For a given clinical set-
ting, this means that for every 35 patients aged >80
with a low/intermediate or “unlikely” clinical prob-
ability of pulmonary embolism, imaging tests can be
avoided in five patients when the conventional cut-off
is used compared with 10 patients when the age
adjusted cut-off value is used. Avoiding imaging tests
(that is, ventilation-perfusion (V/Q) scintigraphy or
Table 3 |Proportion of patients in validation set 1 with an unlikely clinical probability of pulmonary embolism* in whom
pulmonary embolism could be excluded based on a D-dimer test result below the cut-off value: comparison of different cut-
off values stratified by age group
All patients
Age range (years)
51-60 61-70 71-80 >80
No (%) of patients 2158 358 (17) 270 (13) 245 (18) 166 (7.7)
Median (IQR) age (years) 49 (37-66) 55 (52-57) 66 (63-68) 74 (72-77) 84 (82-88)
Conventional cut-off value† †
No (%, 95% CI) ofpatientsbelow cut-off value: 983 (46, 44 to 48) 160(45,40to50) 69 (26, 21 to 31) 40 (16, 12 to 22) 25 (15, 10 to 21)
With false negative result 2 (0.2, 0.1 to 0.7) 0 (0, 0 to 2.3) 0 (0, 0 to 5.3) 0 (0, 0 to 8.8) 0 (0, 0 to 13)
Number needed to test‡ 2.2 2.2 3.9 6.1 6.6
Age adjusted cut-off value† †
No (%, 95% CI) ofpatientsbelow cut-off value: 1093(51,49to53) 179(50,45to55) 96 (36, 30 to 41) 81 (33, 28 to 39) 48 (29, 23 to 36)
With false negative result 7 (0.6, 0.3 to 1.3) 1 (0.6, 0.1 to 3.1) 2 (2.1, 0.6 to 7.3) 1 (1.2, 0.2 to 6.7) 1 (2.1, 0.4 to 11)
Number needed to test‡ 2.0 2.0 2.8 3.0 3.5
Increase in percentage of patients below
cut-off value:
Absolute 5.1 5.3 10 17 14
Relative 11 12 39 103 92
IQR=interquartile range
*Based on Wells clinical decision rule.
†Conventional cut-off value for D-dimer test=500 μg/l, age adjusted cut-off value=(age×10) μg/l (if age >50).
‡Number needed to test to find one normal D-dimer test result
Table 4 |Proportion of patients in validation set 1 with an unlikely clinical probability of
pulmonary embolism* in whom pulmonary embolism could be excluded based on a D-dimer
test result below the cut-off value: comparison of the two D-dimer tests used in the set
D-dimer test P value of
difference Tinaquant Vidas
Conventional cut-off value for D-dimer test† †
No (%) of patients below cut-off value 576/1204 (48) 407/954 (43) 0.016
No(%,95%CI)ofpatientswithfalsenegativeresult 2/576(0.3,0.1to1.3) 0/407 (0, 0 to 0.9) >0.05
Age adjusted cut-off valuefor D-dimer test† †
No (%) of patients below cut-off value 637/1204 (53) 456/954 (48) 0.018
No(%,95%CI)ofpatientswithfalsenegativeresult 4/637(0.6,0.2to1.6) 3/456(0.7,0.2to1.9) >0.05
*Based on Wells clinical decision rule.
†Conventional cut-off value for D-dimer test=500 μg/l, age adjusted cut-off value=(age×10) μg/l (if age >50).
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forolderpatientsbecauseofthehighfrequencyofnon-
conclusive scintigraphy results, the risk from injection
with iodine contrast agent for computed tomography
scanning,andthelengthofhospitalstaywhenordering
imaging tests in this patient population.
Some may argue that having to calculate a D-dimer
cut-off value is impractical in a clinical setting, and that
thenewvalueisreallyaseriesofmultiplecut-offpoints.
However, the treating physician needs to remember
only the coefficient of 10 in order to calculate the new
cut-off value, which is an easy multiplication.
Strengths and limitations of study
The calculation of the age adjusted cut-off value was
facilitated by the large size of the study population,
which is a major strength of this analysis. However,
some aspects of our study warrant comment. Firstly,
two different D-dimer assays were used in the
validation cohorts. Although there was no significant
difference between the two tests, and the new cut-off
value performed equally well with both assays, the
studymaynothavebeensufficientlypoweredtodetect
a difference between the two. It is unknown how the
newcut-offvaluewillperforminotherD-dimerassays.
Secondly,althoughD-dimertestsandthe(variablesfor
the)clinicaldecisionrulewerecollectedprospectively,
thisstudywasaretrospectiveanalysis.Afterderivation
and independent validation in a completely distinct
cohort of patients, the next step would be to validate
this cut-off value prospectively in a formal outcome
study with patient follow-up.
Conclusions
Inconclusion,acut-offvalueadjustedtoagecombined
with clinical probability greatly increased the utility of
theD-dimertestfortheexclusionofpulmonaryembo-
lism among older patients without reducing safety.
This new cut-off is therefore clinically relevant and
has sustained external validation. The next step
would be to validate this new D-dimer cut-off value
prospectively beforeimplementationin dailypractice.
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Table 5 |Proportion of patients in validation set 2 with a non-high clinical probability of pulmonary embolism* in whom
pulmonary embolism could be excluded based on a D-dimer test result below the cut-off value: comparison of different cut-
off values stratified by age group
All patients
Age range (years)
51-60 61-70 71-80 >80
No (%) of patients 1643 252 (15) 260 (16) 333 (20) 253 (15)
Median (IQR) age (years) 61 (45-75) 55 (52-57) 65 (62-67) 75 (72-77) 83 (81-86)
Conventional cut-off value† †
No (%, 95% CI) ofpatientsbelow cut-off value: 561 (34,32to37) 110 (44,38to50) 79 (30, 25 to 36) 43 (13, 10 to 17) 22 (9, 6 to 13)
With false negative result 0 (0, 0 to 0.7) 0 (0, 0 to 3.4) 0 (0, 0 to 4.6) 0 (0, 0 to 8.2) 0 (0, 0 to 15)
Number needed to test‡ 2.9 2.3 3.3 7.7 12
Age adjusted cut-off value† †
No (%, 95% CI) ofpatientsbelow cut-off value: 663 (40,38to43) 115 (46,40to52) 97 (37, 32 to 43) 89 (27, 22 to 32) 54 (21, 17 to 27)
With false negative result 2 (0.3, 0.1 to 1.1) 1 (0.9, 0.2 to 4.8) 0 (0, 0 to 3.8) 1 (1.1, 0.2 to 6.1) 0 (0, 0 to 6.6)
Number needed to test‡ 2.5 2.2 2.7 3.7 4.7
Increase in percentage of patients below
cut-off value:
Absolute 6.2 2.0 6.9 14 13
Relative 18 4.5 23 107 145
IQR=interquartile range
*Based on revised Geneva score <11.
†Conventional cut-off value for D-dimer test=500 μg/l, age adjusted cut-off value=(age×10) μg/l (if age >50).
‡Number needed to test to find one normal D-dimer test result
WHAT IS ALREADY KNOWN ON THIS TOPIC
ThecombinationofD-dimermeasurementandclinicalprobabilityassessmentisvaluable for
investigation of suspected pulmonary embolism
D-dimer concentrations increase with age, and the specificity of the D-dimer test is decreased in
older patients, making the test less useful for excluding pulmonary embolism in such patients
Raisingthecut-offvalue oftheD-dimertestforolderpatientstopointsbetween600 μg/land
1000 μg/l increases the test’s specificity, but at the cost of safety
WHAT THIS STUDY ADDS
An age adjusted D-dimer cut-off value combined with clinical probability assessment
increased the utility of the D-dimer test for excluding pulmonary embolism among older
patients without reducing safety
The new cut-off value has sustained external validation. The next step would be to validate
the new cut-off prospectively before implementation in daily practice
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